[{"Assets_0_FY_USD":181950000.0,"CommonStockSharesOutstanding_0_FY_shares":79087734.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-63381000.0,"NetIncomeLoss_1_FY_USD":-17340000.0,"NetIncomeLoss_4_FY_USD":-96226000.0,"StockholdersEquity_0_FY_USD":146006000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190313"}]